Normal tissue radiosensitivity: prediction on deterministic or stochastic basis?

Area of Science:

• Radiation oncology
• Genetics and personalized medicine
• Molecular biology

Background:

• Patient response to radiation therapy varies significantly, with genetic factors playing a larger role than technical or clinical elements.
• Previous attempts to link in vitro radiosensitivity with clinical outcomes yielded inconsistent results.
• Normal tissue radiation toxicity involves complex biological pathways beyond simple cell kill, including gene product interactions.

Purpose of the Study:

• To explore the genetic basis of interpatient differences in normal tissue radiosensitivity.
• To investigate the potential of gene expression profiling for predicting radiation-induced normal tissue reactions.
• To identify hypersensitive patients for tailored radiotherapy strategies.

Main Methods:

• Analysis of genetic polymorphisms and their association with radiation response.
• Utilizing cDNA microarray to simultaneously measure the expression of thousands of genes.
• Retrospective correlation of gene expression profiles with observed late normal tissue reactions.

Main Results:

• Genetic and epigenetic variations are major contributors to interpatient differences in radiosensitivity.
• Preliminary findings suggest a correlation between late normal tissue reactions and the expression of specific genes.
• Gene expression profiling holds promise for predicting severe late radiation effects.

Conclusions:

• Patient radiosensitivity is influenced by a complex interplay of genetic factors.
• cDNA microarray technology offers a powerful tool for analyzing gene expression and predicting radiation response.
• Predictive biomarkers could enable personalized radiotherapy, improving patient outcomes and safety.